More Globe Newswire

View Older Stories View Newer Stories

Apr 24, 2024 04:05PM Horizon Bancorp, Inc. Reports Solid First Quarter 2024 Results Including EPS of $0.32, Net Interest Margin Expansion, Loan Growth and Well-Managed Operating Expenses
Apr 24, 2024 04:05PM Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Apr 24, 2024 04:05PM Covenant Logistics Group Announces First Quarter Financial and Operating Results
Apr 24, 2024 04:05PM Leslie’s, Inc. to Report Second Quarter Fiscal 2024 Financial Results on May 8, 2024
Apr 24, 2024 04:05PM Dave & Buster’s Appoints New Chief Financial Officer
Apr 24, 2024 04:05PM Eagle Bancorp, Inc. Announces Results of Operations for First Quarter 2024
Apr 24, 2024 04:05PM Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
Apr 24, 2024 04:05PM Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
Apr 24, 2024 04:05PM Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting
Apr 24, 2024 04:05PM ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
Apr 24, 2024 04:05PM Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 15, 2024
Apr 24, 2024 04:05PM FNCB Bancorp, Inc. Declares Second Quarter 2024 Dividend
Apr 24, 2024 04:05PM Mama’s Creations Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Apr 24, 2024 04:05PM Ethan Allen Reports Fiscal 2024 Third Quarter Results Highlighted by Robust Balance Sheet, Strong Cash Dividends and Double-Digit Operating Margin; Lower Demand Reflects Post Pandemic Period
Apr 24, 2024 04:05PM Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing
Apr 24, 2024 04:05PM Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 24, 2024 04:05PM Fossil Group, Inc. Announces Date for First Quarter 2024 Earnings Release and Conference Call
Apr 24, 2024 04:05PM Cardlytics Announces Timing of Its First Quarter 2024 Earnings Release
Apr 24, 2024 04:05PM Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 24, 2024 04:05PM Beyond Meat® to Report First Quarter 2024 Financial Results on May 8, 2024
Apr 24, 2024 04:05PM 23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 24, 2024 04:05PM Appian To Announce First Quarter 2024 Financial Results on May 2
Apr 24, 2024 04:05PM ZimVie to Report First Quarter Financial Results on May 8, 2024
Apr 24, 2024 04:05PM Safe Bulkers, Inc. Sets Date for the First Quarter 2024 Results, Conference Call, and Webcast
Apr 24, 2024 04:05PM QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
Apr 24, 2024 04:05PM NVE Schedules Conference Call on Fourth-Quarter and Fiscal Year Results
Apr 24, 2024 04:05PM NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
Apr 24, 2024 04:05PM ACV to Report First Quarter 2024 Financial Results on May 8, 2024
Apr 24, 2024 04:05PM Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
Apr 24, 2024 04:05PM Amplify Energy Schedules First Quarter 2024 Earnings Release and Conference Call
Apr 24, 2024 04:02PM Churchill Downs Incorporated Reports 2024 First Quarter Results
Apr 24, 2024 04:02PM Finward Bancorp Announces Earnings for the Quarter Ended March 31, 2024
Apr 24, 2024 04:02PM FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Prese
Apr 24, 2024 04:01PM Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 24, 2024 04:01PM Great Lakes Announces New $150,000,000 Second-Lien Financing Agreement
Apr 24, 2024 04:01PM Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event
Apr 24, 2024 04:01PM Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline
Apr 24, 2024 04:01PM Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 24, 2024 04:01PM Capital Southwest Announces Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call Schedule
Apr 24, 2024 04:01PM Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
Apr 24, 2024 04:01PM Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event
Apr 24, 2024 04:01PM Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Apr 24, 2024 04:00PM Cytokinetics to Announce First Quarter Results on May 8, 2024
Apr 24, 2024 04:00PM Verizon to offer Latin music fans the chance to win a VIP experience at La Onda
Apr 24, 2024 04:00PM Splash Beverage Group Names Julius Ivancsits as Chief Financial Officer
Apr 24, 2024 04:00PM HMN Financial, Inc. Announces Dividend
Apr 24, 2024 04:00PM Madrigal Statement on the Passing of Dr. Stephen Harrison
Apr 24, 2024 04:00PM Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Apr 24, 2024 04:00PM InnovAge Launches PACE Center in Los Angeles, Helping Seniors Live Independently with High-Quality Care
Apr 24, 2024 04:00PM The Honest Company to Report First Quarter Financial Results on May 8, 2024
View Newer Stories View Older Stories